DUBLIN, Ireland -- The Jain Pharmaceutical report "Animal Biotechnology - Technologies, Markets and Companies" is now available through Research and Markets.



This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. Knowledge of animal genetics is important in the application of biotechnology to manage genetic disorders and improve animal breeding. Genomics, proteomics and bioinformatics are also being applied to animal biotechnology.



Share of biotechnology-based products and services in 2004 was $4.1 billion out of the total animal healthcare market of $21 billion. This is expected to grow to $5.1 billion by the year 2005 in a total animal healthcare market of $23 billion. Animal biotechnology market is projected to be worth $12.5 billion by the year 2010.

Transgenic technologies are used for improving milk production and the meat in farm animals as well as for creating models of human diseases. Transgenic animals are used for the production of proteins for human medical use. Biotechnology is applied to facilitate xenotransplantation from animals to humans. Genetic engineering is done in farm animals and nuclear transfer technology has become an important and preferred method for cloning animals.



Biotechnology has potential applications in the management of several animal diseases such as foot-and-mouth disease, classical swine fever and bovine spongiform encephalopathy. The most important biotechnology-based products consist of vaccines, particularly genetically engineered or DNA vaccines. Gene therapy for diseases of pet animals is a fast developing area because many of the technologies used in clinical trials humans were developed in animals and many of the diseases of cats and dogs are similar to those in humans.



Molecular diagnosis is assuming an important place in veterinary practice. Polymerase chain reaction and its modifications are considered to be important. Fluorescent in situ hybridization and enzyme-linked immunosorbent assays are also widely used. Newer biochip-based technologies and biosensors are also finding their way in veterinary diagnostics.



Biotechnology products are approved by the Center for Veterinary Medicine of the FDA. Regulatory issues relevant to animal biotechnology are described.



Approximately 92 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Information is given about the research activities of nine veterinary institutes. Important collaborations in this area are shown.



For more information, see http://www.researchandmarkets.com/reports/c1345.



SOURCE: Research and Markets Ltd. via Business Wire.